Oleksiievets, Nazar
Sargsyan, Yelena http://orcid.org/0000-0002-6749-7555
Thiele, Jan Christoph http://orcid.org/0000-0002-6638-6298
Mougios, Nikolaos
Sograte-Idrissi, Shama http://orcid.org/0000-0003-4271-7897
Nevskyi, Oleksii http://orcid.org/0000-0003-2893-481X
Gregor, Ingo http://orcid.org/0000-0002-1775-2159
Opazo, Felipe http://orcid.org/0000-0002-4968-9713
Thoms, Sven
Enderlein, Jörg http://orcid.org/0000-0001-5091-7157
Tsukanov, Roman http://orcid.org/0000-0002-3967-1755
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 2067/1–390729940)
Article History
Received: 25 May 2021
Accepted: 8 December 2021
First Online: 11 January 2022
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: F.O. is a shareholder of NanoTag Biotechnologies GmbH. All other authors declare no competing interest.